Increased antibiotics use in combating the COVID-19 pandemic will strengthen bacterial resistance and ultimately lead to more deaths during the crisis and beyond, the World Health Organisation said Monday.
WHO director general Tedros Adhanom Ghebreyesus said a ‘worrying number’ of bacterial infections were becoming increasingly resistant to the medicines traditionally used to treat them.
The UN health agency said it was concerned that the inappropriate use of antibiotics during the coronavirus crisis would further fuel the trend. ‘The COVID-19 pandemic has led to an increased use of antibiotics, which ultimately will lead to higher bacterial resistance rates that will impact the burden of disease and deaths during the pandemic and beyond,’ Tedros told a virtual press conference from the WHO’s Geneva headquarters.
The WHO said only a small proportion of COVID-19 patients needed antibiotics to treat subsequent bacterial infections.
The organisation has issued guidance to medics not to provide antibiotic therapy or prophylaxis to patients with mild COVID-19, or to patients with moderate illness without a clinical suspicion of bacterial infection.
Tedros said the guidelines said should help tackle antimicrobial resistance while saving lives.
He called the threat of antimicrobial resistance ‘one of the most urgent challenges of our time’.
‘It’s clear that the world is losing its ability to use critically important antimicrobial medicines,’ he said.
Highlighting inappropriate usage, he said there was an ‘overuse’ of antibiotics in some countries, while in low-income states, such life-saving medicines were unavailable, ‘leading to needless suffering and death’.
Meanwhile the WHO said the prevention and treatment of non-communicable diseases had been severely disrupted since the COVID-19 pandemic began in December, following a survey of 155 countries.
‘This situation is of significant concern because people living with NCDs are at higher risk of severe COVID-19-related illness and death,’ it said.
The survey, during a three-week period in May, found that low-income countries were most affected. Some 53 per cent of countries reported partially or completely disrupted services for hypertension treatment.
The figure was 49 per cent for diabetes treatment and related complications; 42 per cent for cancer treatment, and 31 per cent for cardiovascular emergencies.
The most common reasons for discontinuing or reducing services were cancellations of planned treatments, a decrease in available public transport and a lack of staff because health workers had been reassigned to COVID-19 treatment.
Want stories like this in your inbox?
Sign up to exclusive daily email
More Stories from Miscellany